| 000 | 01698 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513082816.0 | ||
| 264 | 0 | _c19930709 | |
| 008 | 199307s 0 0 eng d | ||
| 022 | _a0003-9861 | ||
| 024 | 7 |
_a10.1006/abbi.1993.1289 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBlouin, R A | |
| 245 | 0 | 0 |
_aCytochrome P450 2B enzyme (CYP2B) induction defect following phenobarbital treatment in the fa/fa Zucker rat: molecular characterization. _h[electronic resource] |
| 260 |
_bArchives of biochemistry and biophysics _cJun 1993 |
||
| 300 |
_a313-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBlotting, Northern |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aCytochrome P-450 CYP2B1 |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xgenetics |
| 650 | 0 | 4 | _aDNA Probes |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aObesity _xenzymology |
| 650 | 0 | 4 |
_aOxazines _xmetabolism |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 |
_aOxidoreductases _xgenetics |
| 650 | 0 | 4 |
_aPhenobarbital _xpharmacology |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Zucker |
| 650 | 0 | 4 |
_aTestosterone _xmetabolism |
| 650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
| 700 | 1 | _aBandyopadhyay, A M | |
| 700 | 1 | _aChaudhary, I | |
| 700 | 1 | _aRobertson, L W | |
| 700 | 1 | _aGemzik, B | |
| 700 | 1 | _aParkinson, A | |
| 773 | 0 |
_tArchives of biochemistry and biophysics _gvol. 303 _gno. 2 _gp. 313-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1006/abbi.1993.1289 _zAvailable from publisher's website |
| 999 |
_c8511586 _d8511586 |
||